SCHEMBL3319630

SCHEMBL3319630

Cc1ccc(C(=O)C2(O)CCCCC2C(=O)OCCOCCO)cc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
HTT P42858 2/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
FKBP1A P62942 3/20 0.32
FKBP4 Q02790 1/20 0.32
FKBP5 Q13451 1/20 0.32
KDM4E B2RXH2 2/20 0.31
XBP1 P17861 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
CHRM2 P08172 2/20 0.31
CHRM1 P11229 2/20 0.31
KDM2B Q8NHM5 1/20 0.31
KMT2A Q03164 2/20 0.31
SLC22A1 O15245 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3317309 1.00 ALDH1A1 (0.34) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3321538 0.96 ALDH1A1 (0.37) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3316283 0.96 ALDH1A1 (0.37) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3316766 0.90 FKBP1A (0.39) NPC1RAB9AFKBP1AFKBP4FKBP5
SCHEMBL3316688 0.88 NPC1 (0.35) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3318665 0.87 NPC1 (0.38) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL13397746 0.87 NPC1 (0.38) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3318629 0.86 HTT (0.39) ALDH1A1HTTNPC1RAB9AL3MBTL1
SCHEMBL3315534 0.85 CHRM2 (0.42) ALDH1A1NPC1RAB9AL3MBTL1FKBP1A
SCHEMBL3320618 0.85 CHRM2 (0.42) ALDH1A1NPC1RAB9AL3MBTL1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199934-B2 Alpha-hydroxyketones BASF SE (DE) 2015-12-01 US disclosed
EP-2129659-B1 ALPHA-HYDROXYKETONES BASF SE (DE) 2013-05-29 EP disclosed
US-20100104979-A1 ALPHA-HYDROXYKETONES IGM GROUP B.V. (NL) 2010-04-29 US disclosed
EP-2129659-A1 ALPHA-HYDROXYKETONES BASF SE (DE) 2009-12-09 EP disclosed
WO-2008122504-A1 ALPHA-HYDROXYKETONES BASF SE (CH) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100104979-A1 ALPHA-HYDROXYKETONES C9, C1R, CBR3 ALDH1A1 734/4885HTT 3319/4885NPC1 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.